A New Test Could Save Arthritis Patients Time, Money and Pain. But Will It Be Used?

[ad_1]

Editor's Note: This story originally appeared on KFF Health News. SAN DIEGO — Erinn Maury knew Remicade wasn’t the right drug for Patti Schulte, a rheumatoid arthritis patient the physician saw at her Millersville, Maryland, practice. Schulte’s swollen, painful joints hadn’t responded to Enbrel or Humira, two drugs in the same class. But the insurer insisted, so Schulte went on Remicade.

[ad_2]

Karla Bowsher (KFF Health News)

Source link